Now, in a new study in the journal Cancer Cell, Shaw and a team of scientists at the Salk Institute for Biological Studies found that phenformin, a derivative of the widely -
used diabetes drug metformin, decreased the size of lung tumors in mice and increased the animals» survival.
Emory cardiologist Aloke Finn and his colleagues recently had two papers in the Journal of the American College of Cardiology and in Atherosclerosis describing a possible interaction between the widely
used diabetes drug metformin and drug - eluting stents, which are used to to treat coronary artery disease.
Not exact matches
Metformin, a commonly
used drug for treating type 2
diabetes, is linked to an increased risk of low thyroid - stimulating hormone (TSH) levels in patients with underactive thyroids (hypothyroidism), according to a study in CMAJ (Canadian Medical Association Journal).
As published in the article, his lab team determined that
metformin, a
drug commonly
used to treat type II
diabetes, reduces the intensity of seizures.
In a report published this week in Proceedings of the National Academy of Sciences (PNAS), investigators say
metformin, an inexpensive
drug commonly
used to treat patients with type 2
diabetes, appears to block symptoms of nicotine withdrawal in rodents.
A widely
used diabetes drug,
metformin, which extends life in mice, will soon be tested in non-diabetic elderly people.
The other was
metformin, a
drug used to help lower blood - sugar levels in people with type 2
diabetes.
Now researchers in the U.S. and Canada want to hold the first anti-aging clinical trial to see if they can replicate the same effect in humans
using a
diabetes drug called
metformin.
Metformin, a
drug widely
used in type 2
diabetes, also activates autophagy but not through mTOR.
In fact, NDs are pioneers in the
use of both new therapies featured this month: sublingual immunotherapy (SLIT) for allergy desensitization, as well as
use of the
diabetes drug,
metformin, in fighting cancer.